Status:
WITHDRAWN
The Role of Tranexamic Acid in Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass in Neonates
Lead Sponsor:
Aymen N Naguib
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
Up to 28 years
Brief Summary
This is an observational, prospective study to evaluate the role of tranexamic acid in reducing blood transfusion in neonates undergoing cardiopulmonary bypass.
Eligibility Criteria
Inclusion
- All neonates undergoing arterial switch or aortic arch procedure utilizing cardiopulmonary bypass (CPB).
Exclusion
- Jehovah's witness patients.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01914211
Start Date
July 1 2013
End Date
June 1 2014
Last Update
February 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205